Keiichi Mitsuyama

7.9k total citations
158 papers, 5.3k citations indexed

About

Keiichi Mitsuyama is a scholar working on Genetics, Epidemiology and Molecular Biology. According to data from OpenAlex, Keiichi Mitsuyama has authored 158 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Genetics, 51 papers in Epidemiology and 36 papers in Molecular Biology. Recurrent topics in Keiichi Mitsuyama's work include Inflammatory Bowel Disease (74 papers), Microscopic Colitis (26 papers) and Gut microbiota and health (23 papers). Keiichi Mitsuyama is often cited by papers focused on Inflammatory Bowel Disease (74 papers), Microscopic Colitis (26 papers) and Gut microbiota and health (23 papers). Keiichi Mitsuyama collaborates with scholars based in Japan, United States and Germany. Keiichi Mitsuyama's co-authors include Michio Sata, Atsushi Toyonaga, Osamu Kanauchi, Akira Andoh, Satoshi Matsumoto, Yoshihide Fujiyama, Asuka Suzuki, Osamu Tsuruta, Yoshio Araki and Stefan Rose‐John and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Gastroenterology.

In The Last Decade

Keiichi Mitsuyama

152 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keiichi Mitsuyama Japan 40 1.9k 1.7k 1.2k 1.1k 956 158 5.3k
Shigeki Bamba Japan 38 1.9k 1.0× 2.5k 1.5× 1.4k 1.2× 1.1k 1.0× 752 0.8× 146 6.2k
Osamu Inatomi Japan 30 1.4k 0.7× 2.2k 1.3× 1.2k 1.0× 819 0.8× 528 0.6× 134 5.0k
Tomoyuki Tsujikawa Japan 35 1.7k 0.9× 1.3k 0.8× 1.4k 1.2× 966 0.9× 608 0.6× 145 5.3k
Laurent Dubuquoy France 40 1.4k 0.7× 2.6k 1.6× 1.1k 0.9× 1.3k 1.2× 708 0.7× 104 6.1k
Tadao Bamba Japan 33 1.1k 0.6× 1.3k 0.7× 1.1k 0.9× 512 0.5× 665 0.7× 160 4.2k
Atsushi Nishida Japan 29 1.1k 0.6× 2.3k 1.4× 949 0.8× 646 0.6× 522 0.5× 104 4.5k
Benno Weigmann Germany 32 2.1k 1.1× 2.6k 1.5× 3.7k 3.0× 886 0.8× 1.1k 1.2× 85 7.6k
Giorgos Bamias Greece 44 2.2k 1.2× 1.4k 0.8× 2.2k 1.9× 1.2k 1.1× 574 0.6× 131 5.4k
Alexandra W. C. Einerhand Netherlands 41 1.1k 0.6× 2.8k 1.7× 918 0.8× 481 0.4× 484 0.5× 96 5.8k
Toshifumi� Ohkusa Japan 36 1.5k 0.8× 2.0k 1.2× 1.0k 0.9× 872 0.8× 550 0.6× 142 6.0k

Countries citing papers authored by Keiichi Mitsuyama

Since Specialization
Citations

This map shows the geographic impact of Keiichi Mitsuyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiichi Mitsuyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiichi Mitsuyama more than expected).

Fields of papers citing papers by Keiichi Mitsuyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiichi Mitsuyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiichi Mitsuyama. The network helps show where Keiichi Mitsuyama may publish in the future.

Co-authorship network of co-authors of Keiichi Mitsuyama

This figure shows the co-authorship network connecting the top 25 collaborators of Keiichi Mitsuyama. A scholar is included among the top collaborators of Keiichi Mitsuyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiichi Mitsuyama. Keiichi Mitsuyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Takedatsu, Hidetoshi, Keiichi Mitsuyama, Masaru Morita, et al.. (2022). Role of Serum Proteinase 3 Antineutrophil Cytoplasmic Antibodies in the Diagnosis, Evaluation of Disease Severity, and Clinical Course of Ulcerative Colitis. Gut and Liver. 16(1). 92–100. 12 indexed citations
3.
Mitsuyama, Keiichi, et al.. (2021). Characteristics of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review. The Kurume Medical Journal. 68(2). 43–52. 2 indexed citations
4.
Mitsuyama, Keiichi, Hiroshi Yamasaki, Atsushi Mori, et al.. (2020). Gene Expression of Transient Receptor Potential Channels in Peripheral Blood Mononuclear Cells of Inflammatory Bowel Disease Patients. Journal of Clinical Medicine. 9(8). 2643–2643. 15 indexed citations
5.
Arinaga‐Hino, Teruko, Hironori Koga, Jun Akiba, et al.. (2018). Marked accumulation of fluorodeoxyglucose and inflammatory cells expressing glucose transporter‐3 in immunoglobulin G4‐related autoimmune hepatitis. Hepatology Research. 48(11). 937–944. 6 indexed citations
6.
Fukunaga, Shuhei, Kotaro Kuwaki, Keiichi Mitsuyama, et al.. (2017). Detection of Calprotectin in Inflammatory Bowel Disease: Fecal and Serum Levels and Immonohistchemical Localization. Gastroenterology. 152(5). S769–S770.
7.
Kominato, Ken, Hiroshi Yamasaki, Keiichi Mitsuyama, et al.. (2016). Increased levels of circulating adrenomedullin following treatment with TU-100 in patients with Crohn's disease. Molecular Medicine Reports. 14(3). 2264–2268. 5 indexed citations
8.
Nagayama, Koji, Hidetoshi Takedatsu, Keiichi Mitsuyama, et al.. (2014). Univariate Analysis to Examine Predictors of Response to Leukocytapheresis in Ulcerative Colitis Patients. Therapeutic Apheresis and Dialysis. 18(3). 244–251. 1 indexed citations
9.
Mitsuyama, Keiichi, Hiroshi Yamasaki, Junya Masuda, et al.. (2013). Microarray analyses of peripheral whole blood cells from ulcerative colitis patients: Effects of leukocytapheresis. International Journal of Molecular Medicine. 31(4). 789–796. 5 indexed citations
10.
Hiwatashi, Nobuo, Yasuo Suzuki, Keiichi Mitsuyama, Akihiro Munakata, & Toshifumi Hibi∥. (2010). Clinical trial: effects of an oral preparation of mesalazine at 4 g/day on moderately active ulcerative colitis. A phase III parallel-dosing study. Journal of Gastroenterology. 46(1). 46–56. 25 indexed citations
11.
12.
Mitsuyama, Keiichi, Hiroshi Yamasaki, Kotaro Kuwaki, Hidetoshi Takedatsu, & Michio Sata. (2009). Recent Understanding of Leukocytapheresis (LCAP) for the Treatment of Inflammatory Bowel Disease. Current Pharmaceutical Design. 15(18). 2110–2119. 11 indexed citations
13.
Andoh, Akira, Tomoyuki Tsujikawa, Masaya Sasaki, et al.. (2008). Faecal microbiota profile of Crohn’s disease determined by terminal restriction fragment length polymorphism analysis. Alimentary Pharmacology & Therapeutics. 29(1). 75–82. 56 indexed citations
14.
Mitsuyama, Keiichi, Akira Andoh, Junya Masuda, et al.. (2008). Mobilization of Bone Marrow Cells by Leukocytapheresis in Patients With Ulcerative Colitis. Therapeutic Apheresis and Dialysis. 12(4). 271–277. 12 indexed citations
15.
Okabe, Yoshinobu, Osamu Tsuruta, Yusuke Ishida, et al.. (2008). ENDOSCOPIC RETRIEVAL OF MIGRATED PLASTIC STENT INTO BILE DUCT OR PANCREATIC PSEUDOCYST. Digestive Endoscopy. 21(1). 1–7. 6 indexed citations
16.
Mitsuyama, Keiichi, Satoshi Matsumoto, Junya Masuda, et al.. (2007). Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease.. PubMed. 27(6A). 3749–56. 70 indexed citations
17.
Masuda, Junya, Keiichi Mitsuyama, Hiroshi Yamasaki, et al.. (2007). Depletion of endothelial progenitor cells in the peripheral blood of patients with ulcerative colitis. International Journal of Molecular Medicine. 19(2). 221–8. 15 indexed citations
18.
Mitsuyama, Keiichi, O. Tsuruta, Yasuhisa Matsui, et al.. (2005). Activation of c-Jun N-terminal kinase (JNK) signalling in experimentally induced gastric lesions in rats. Clinical & Experimental Immunology. 143(1). 24–29. 27 indexed citations
19.
Kanauchi, Osamu, Keiichi Mitsuyama, Yoshio Araki, & Akira Andoh. (2003). Modification of Intestinal Flora in the Treatment of Inflammatory Bowel Disease. Current Pharmaceutical Design. 9(4). 333–346. 73 indexed citations
20.
Mitsuyama, Keiichi, et al.. (2001). Transcription Factor-Targeted Therapies in Inflammatory Bowel Disease. Digestion. 63(Suppl. 1). 68–72. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shigeki Bamba Breakdown of academic impact, for papers by Osamu Inatomi Breakdown of academic impact, for papers by Tomoyuki Tsujikawa Breakdown of academic impact, for papers by Laurent Dubuquoy Breakdown of academic impact, for papers by Tadao Bamba Breakdown of academic impact, for papers by Atsushi Nishida Breakdown of academic impact, for papers by Benno Weigmann Breakdown of academic impact, for papers by Giorgos Bamias Breakdown of academic impact, for papers by Alexandra W. C. Einerhand Breakdown of academic impact, for papers by Toshifumi� Ohkusa
Rankless by CCL
2026